WorthPointe LLC Buys New Stake in HCA Healthcare, Inc. $HCA

WorthPointe LLC bought a new stake in HCA Healthcare, Inc. (NYSE:HCA) in the 2nd quarter, according to its most recent filing with the SEC. The fund bought 530 shares of the company’s stock, valued at approximately $203,000.

Several other large investors have also recently made changes to their positions in the company. Price T Rowe Associates Inc. MD lifted its stake in shares of HCA Healthcare by 83.4% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 2,399,372 shares of the company’s stock valued at $829,104,000 after purchasing an additional 1,091,416 shares during the period. Goldman Sachs Group Inc. raised its position in HCA Healthcare by 49.1% during the first quarter. Goldman Sachs Group Inc. now owns 1,781,459 shares of the company’s stock worth $615,583,000 after acquiring an additional 587,036 shares during the period. Nuveen LLC acquired a new position in HCA Healthcare during the first quarter worth $569,217,000. Pacer Advisors Inc. raised its position in HCA Healthcare by 6,237.9% during the first quarter. Pacer Advisors Inc. now owns 1,350,933 shares of the company’s stock worth $466,815,000 after acquiring an additional 1,329,618 shares during the period. Finally, Nordea Investment Management AB raised its position in HCA Healthcare by 6.8% during the second quarter. Nordea Investment Management AB now owns 927,781 shares of the company’s stock worth $350,404,000 after acquiring an additional 59,163 shares during the period. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In related news, EVP Michael S. Cuffe sold 3,836 shares of HCA Healthcare stock in a transaction that occurred on Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the completion of the transaction, the executive vice president owned 31,503 shares in the company, valued at $13,194,716.52. The trade was a 10.85% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 1.30% of the company’s stock.

HCA Healthcare Trading Up 0.3%

Shares of HCA opened at $460.84 on Tuesday. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $478.19. The firm has a 50-day moving average price of $422.26 and a 200 day moving average price of $388.13. The firm has a market capitalization of $107.83 billion, a P/E ratio of 17.81, a P/E/G ratio of 1.38 and a beta of 1.40.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Friday, October 24th. The company reported $6.96 earnings per share for the quarter, topping the consensus estimate of $5.64 by $1.32. The company had revenue of $19.16 billion during the quarter, compared to analyst estimates of $18.55 billion. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. HCA Healthcare’s revenue was up 9.6% compared to the same quarter last year. During the same quarter last year, the firm posted $4.90 earnings per share. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. Equities research analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, December 29th. Stockholders of record on Monday, December 15th will be given a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a dividend yield of 0.6%. The ex-dividend date of this dividend is Monday, December 15th. HCA Healthcare’s dividend payout ratio is currently 11.13%.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on HCA. Mizuho upped their price objective on shares of HCA Healthcare from $475.00 to $505.00 and gave the stock an “outperform” rating in a research report on Monday, October 27th. Stephens upped their target price on shares of HCA Healthcare from $450.00 to $500.00 and gave the stock an “overweight” rating in a report on Monday, October 27th. Bank of America upped their target price on shares of HCA Healthcare from $430.00 to $470.00 and gave the stock a “neutral” rating in a report on Monday, October 27th. Wells Fargo & Company upped their target price on shares of HCA Healthcare from $375.00 to $412.00 and gave the stock an “equal weight” rating in a report on Tuesday, October 7th. Finally, TD Cowen upped their target price on shares of HCA Healthcare from $380.00 to $490.00 and gave the stock a “buy” rating in a report on Monday, October 27th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and ten have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $473.53.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.